Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 1 to 50 of 3228 in total 
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1038\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03148\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
186.664\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.943\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03162\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1048\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.308\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1043\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03128\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 (ec 3.1.4.11) (phosphoinositide phospholipase c) (plc-beta-4) (phospholipase c-beta-4). [source:swissprot;acc:q15147]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3126\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1963\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.633\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.703\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
10-formyltetrahydrofolate dehydrogenase (ec 1.5.1.6) (10-fthfdh). [source:swissprot;acc:o75891]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2922\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.681\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.425\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein epsilon (mitochondrial import stimulation factor l subunit) (protein kinase c inhibitor protein-1) (kcip-1) (14-3-3e). [source:swissprot;acc:p42655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3088\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14-3-3 protein zeta/delta (protein kinase c inhibitor protein-1) (kcip-1) (factor activating exoenzyme s) (fas). [source:swissprot;acc:p29312]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2396\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.683\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
14.5 kda translational inhibitor protein (p14.5) (uk114 antigen homolog). [source:swissprot;acc:p52758]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2366\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.353\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1948\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.522\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00984\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15-hydroxyprostaglandin dehydrogenase [nad(+)] (ec 1.1.1.141) (pgdh). [source:swissprot;acc:p15428]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2855\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
17 beta-hydroxysteroid dehydrogenase. [source:sptrembl;acc:q13034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1051\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.449\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03097\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-hydroxyphytanoyl-coa lyase (ec 4.1.-.-) (2-hpcl) (hspc279). [source:swissprot;acc:q9uj83]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2007\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.019\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00919\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoglutarate dehydrogenase e1 component, mitochondrial precursor (ec 1.2.4.2) (alpha-ketoglutarate dehydrogenase). [source:swissprot;acc:q02218]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1160\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02633\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1484\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.927\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.726\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0191\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component beta chain) (bckdh e1-beta). [source:swissprot;acc:p21953]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1389\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02148\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
183\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.306\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.011\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3079\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 4 (p26s4). [source:swissprot;acc:q03527]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2503\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.581\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 6a (tat-binding protein 1) (tbp-1) (proteasome subunit p50). [source:swissprot;acc:p17980]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2474\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.285\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2327\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.413\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.426\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00466\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 7 (mss1 protein). [source:swissprot;acc:p35998]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2395\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.192\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.014\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00377\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit 8 (proteasome subunit p45) (thyroid hormone receptor interacting protein 1) (trip1) (msug1 protein) (tat-binding protein homolog 10) (tbp10) (p45/sug). [source:swissprot;acc:p47210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.358\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.408\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01479\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2478\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.177\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.801\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00289\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 1 (26s proteasome regulatory subunit s1) (26s proteasome subunit p112). [source:swissprot;acc:q99460]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2368\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.555\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.434\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2269\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.419\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00556\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2367\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.589\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2316\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.311\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2329\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.112\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00462\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2175\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.209\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.808\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2440\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.645\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.376\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1432\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.987\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2432\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.556\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit s12) (proteasome subunit p40) (mov34 protein homolog). [source:swissprot;acc:p51665]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2355\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 8 (26s proteasome regulatory subunit s14) (p31). [source:swissprot;acc:p48556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2525\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.835\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.341\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00234\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 9 (26s proteasome regulatory subunit p27). [source:swissprot;acc:o00233]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2620\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.615\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
26s proteasome-associated pad1 homolog. [source:refseq;acc:nm\_005805]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2150\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.871\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00686\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
810\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s12, mitochondrial precursor (mpr-s12) (mt- rps12). [source:swissprot;acc:o15235]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
325\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
243.944\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
268.195\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09941\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2212\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00643\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s18a, mitochondrial precursor (mrp-s18-a) (mrps18a) (mrp-s18-3). [source:swissprot;acc:q9nvs2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1659\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.925\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.826\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01443\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s26, mitochondrial precursor (mrp-s26) (mrp- s13). [source:swissprot;acc:q9byn8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2675\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.108\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28s ribosomal protein s9, mitochondrial precursor (mrp-s9). [source:swissprot;acc:p82933]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
407\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
260.544\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08673\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxy-delta 5-c27-steroid oxidoreductase. [source:refseq;acc:nm\_025193]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3147\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2756\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type i (3beta-hsd i) (trophoblast antigen fdo161g) [includes: 3-beta-hydroxy- delta(5)-steroid dehydrogenase (ec 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (progesterone reductase); steroid delta- isomerase (ec 5.3.3.1) (delta-5-3-ketosteroid isomerase)]. [source:swissprot;acc:p14060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2802\vspace{3pt}}&&&\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/